Candidate for electroconvulsive therapy. Medical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Conditions
Interventions
Intervention 1: First intervention group: In this group, patients receive 0.5 mg/kg of succinylcholine and 2 mg/kg of sodium thiopental before electroconvulsive therapy. Intervention 2: Second interve
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients who are candidates for electroconvulsive therapy (such as patients with schizophrenia, major depression, bipolar disorder in the manic phase) Over the age of 18 Patients who have not responded adequately to medication or the individual/guardian is willing to undergo electroconvulsive therapy Patients who are at serious risk of suicide or harm to others if they do not receive electroconvulsive therapy Consent to participate in the study
Exclusion criteria
Exclusion criteria: Having a recent history of cardiovascular diseases such as myocardial infarction or congestive heart failure Having brain tumors, cerebral aneurysms or any increased intracranial pressure Patients with uncontrolled heart failure Patients at risk of anesthesia (ASA level 4-5)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Seizure time. Timepoint: During the electroconvulsive therapy process. Method of measurement: Time in minutes.;Seizure threshold. Timepoint: During the electroconvulsive therapy process. Method of measurement: Based on electrocardiogram (ECG). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Behzad Nazemroaya
Esfahan University of Medical Sciences
Outcome results
None listed